INVIVO THERAPEUTICS HOLDINGS CORP. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
  • Invivo Therapeutics Holdings Corp. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$2.7M, a 2.11% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$9.33M, a 15.5% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$10.5M, a 6.01% decline from 2021.
  • Invivo Therapeutics Holdings Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$9.9M, a 9.05% decline from 2020.
  • Invivo Therapeutics Holdings Corp. annual Net Income (Loss) Attributable to Parent for 2020 was -$9.07M, a 23.3% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$10.5M -$595K -6.01% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 -$9.9M -$821K -9.05% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 -$9.07M +$2.76M +23.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
2019 -$11.8M +$11.6M +49.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$23.4M +$3.32M +12.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-20
2017 -$26.7M -$3.31M -14.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$23.4M +$9.88M +29.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
2015 -$33.3M -$15M -81.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$18.3M +$20.4M +52.7% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-04
2013 -$38.8M -$43.4M -931% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 $4.66M +$39.4M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
2011 -$34.7M -$26.8M -339% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 -$7.91M Jan 1, 2010 Dec 31, 2010 10-K 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.